← Leaderboards

Warren C. Ladiges

University Of Washington

Google Scholar ↗PubMed ↗ORCID ↗

$25,544,366

Attributed

$27,762,167

Total exposure

19

Grants

16

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$27,762,167 · 19

By mechanism

R01$8,391,238 · 2

U01$7,243,395 · 1

P30$3,398,538 · 2

P01$3,225,353 · 5

R24$1,523,796 · 2

U19$1,454,929 · 1

Top collaborators

Martin C Darvas6 shared

Most similar at University Of Washington

Same institution · by research overlap

Peter S Rabinovitch$49,936,459
Raymond J Monnat$11,516,060
Steven N. Austad$17,360,109
George M. Martin$5,470,369
Lawrence A Loeb$30,079,700

Others in their field

Top investigators on “Aging”

Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
David R. Weir · University Of Michigan At Ann Arbor$421,002,438
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
George R Seage · Abt Associates, Inc.$218,167,298
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900

Research focus

AgingTissuesDesignLaboratory MouseGenetically Modified AnimalsPhenotypeGene ExpressionMouse ModelGene TargetingResourcesPhysiologicalStressBaseAnimalsAlzheimer&AposModel Design /DevelopmentLesionAge RelatedPharmaceutical PreparationsResponseCohortPathologicMiddle AgeUniversities

Grant awards (84)

Physical resilience is a predictor of healthy aging$645,964

R01 · FY2025 · AG · contact PI

A geroscience approach for treating Alzheimer's disease$777,433

R01 · FY2024 · AG · contact PI

Physical resilience is a predictor of healthy aging$659,148

R01 · FY2024 · AG · contact PI

A geroscience approach for treating Alzheimer's disease$777,433

R01 · FY2023 · AG · contact PI

Physical resilience is a predictor of healthy aging$673,023

R01 · FY2023 · AG · contact PI

A geroscience approach for treating Alzheimer's disease$777,433

R01 · FY2022 · AG · contact PI

A geroscience approach for treating Alzheimer's disease$777,433

R01 · FY2021 · AG · contact PI

A geroscience approach for investigating resilience to SARS-CoV-2 pathology in mice with Alzheimer's disease$548,438

R01 · FY2021 · AG · contact PI

Physical resilience is a predictor of healthy aging in mice$317,750

R01 · FY2021 · AG · contact PI

Core B: Murine Healthspan and Longevity$194,174

P01 · FY2021 · AG · contact PI

A geroscience approach for treating Alzheimer's disease$777,433

R01 · FY2020 · AG · contact PI

A model of sleep-deprived neuropathology to study resilience to Alzheimers Disease$388,750

R01 · FY2020 · AG · contact PI

Transgenic and Geropathology Core$336,371

U19 · FY2020 · AG · contact PI

Physical resilience is a predictor of healthy aging in mice$317,750

R01 · FY2020 · AG · contact PI

Core B: Murine Healthspan and Longevity$194,174

P01 · FY2020 · AG · contact PI

Transgenic and Geropathology Core$323,084

U19 · FY2019 · AG · contact PI

Physical resilience is a predictor of healthy aging in mice$317,750

R01 · FY2019 · AG · contact PI

Core B: Murine Healthspan and Longevity$194,174

P01 · FY2019 · AG · contact PI

Slowing aging by multiplexing (SLAM)$866,759

R56 · FY2018 · AG · contact PI

Transgenic and Geropathology Core$323,043

U19 · FY2018 · AG · contact PI

Physical resilience is a predictor of healthy aging in mice$317,750

R01 · FY2018 · AG · contact PI

Core B: Murine Healthspan and Longevity$213,807

P01 · FY2018 · AG · contact PI

Transgenic and Geropathology Core$137,941

U19 · FY2018 · AG · contact PI

Transgenic and Geropathology Core$334,490

U19 · FY2017 · AG · contact PI

Physical resilience is a predictor of healthy aging in mice$317,750

R01 · FY2017 · AG · contact PI

Core B: Murine Healthspan and Longevity$193,900

P01 · FY2017 · AG · contact PI

Pathology of Aging Research Network$386,250

R24 · FY2016 · AG · contact PI

Pathology of Aging Research Network$374,662

R24 · FY2015 · AG · contact PI

Pathology of Aging Research Network$366,250

R24 · FY2014 · AG · contact PI

PATHOBIOLOGY$302,839

P01 · FY2011 · AG · contact PI

Mitochondrial ROS, Aging and Cancer$297,921

P01 · FY2011 · AG · contact PI

Mitochondrial catalase as a treatment for metastatic breast cancer$205,823

R21 · FY2010 · CA · contact PI

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$408,243

P30 · FY2009 · AG · contact PI

Cancer susceptibility of XRCC1 mutant mice$234,000

R21 · FY2009 · ES · contact PI

Mitochondrial catalase as a treatment for metastatic breast cancer$171,600

R21 · FY2009 · CA · contact PI

CORE--Transgenic Animal Support$89,635

P30 · FY2009 · ES · contact PI

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$335,506

P30 · FY2008 · AG · contact PI

Cancer susceptibility of XRCC1 mutant mice$195,000

R21 · FY2008 · ES · contact PI

Mouse Core$171,489

P01 · FY2008 · CA · contact PI

CORE--Transgenic Animal Support$91,480

P30 · FY2008 · ES · contact PI

CORE--ANIMAL PATHOBIOLOGY$580,079

P01 · FY2007 · AG · contact PI

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$326,695

P30 · FY2007 · AG · contact PI

Mouse Core$169,811

P01 · FY2007 · CA · contact PI

CORE--Transgenic Animal Support$94,214

P30 · FY2007 · ES · contact PI

Comparative Mouse Genomics Center$691,692

U01 · FY2006 · ES · contact PI

CORE--ANIMAL PATHOBIOLOGY$395,659

P01 · FY2006 · AG · contact PI

Alzheimer's Disease and Impaired APP Proteolysis$193,708

R21 · FY2006 · AG · contact PI

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$161,259

P30 · FY2006 · AG · contact PI

Mouse Core$108,917

P01 · FY2006 · CA · contact PI

CORE--Transgenic Animal Support$74,986

P30 · FY2006 · ES · contact PI

Comparative Mouse Genomics Center$1,362,645

U01 · FY2005 · ES

Alzheimer's Disease and Impaired APP Proteolysis$165,219

R21 · FY2005 · AG

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$156,563

P30 · FY2005 · AG

Mouse Core$105,745

P01 · FY2005 · CA

CORE--Transgenic Animal Support$72,801

P30 · FY2005 · ES

Comparative Mouse Genomics Center$1,325,148

U01 · FY2004 · ES

Mouse Core$102,664

P01 · FY2004 · CA

IMMUNOBIOLOGY OF AGING IN GENETICALLY ALTERED MICE$87,428

K26 · FY2004 · AG

Comparative Mouse Genomics Center$1,206,544

U01 · FY2003 · ES

Comparative Mouse Genomics Center$100,000

U01 · FY2003 · ES

IMMUNOBIOLOGY OF AGING IN GENETICALLY ALTERED MICE$85,668

K26 · FY2003 · AG

Comparative Mouse Genomics Center$1,169,626

U01 · FY2002 · ES

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$193,750

P30 · FY2002 · AG

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$193,750

P30 · FY2002 · AG

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$193,750

P30 · FY2002 · AG

Comparative Mouse Genomics Center$100,001

U01 · FY2002 · ES

IMMUNOBIOLOGY OF AGING IN GENETICALLY ALTERED MICE$83,960

K26 · FY2002 · AG

CORE--TRANSGENIC ANIMAL SUPPORT$73,467

P30 · FY2002 · ES

Comparative Mouse Genomics Center$52,302

U01 · FY2002 · ES

Comparative Mouse Genomics Center$45,007

U01 · FY2002 · ES

Comparative Mouse Genomics Center$1,190,430

U01 · FY2001 · ES

TRANSGENIC ANIMAL MODEL DEVELOPMENT--PKR PROTEIN KINASE$201,148

R24 · FY2001 · RR

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$193,750

P30 · FY2001 · AG

CORE--TRANSGENIC ANIMAL SUPPORT$117,868

P30 · FY2001 · ES

CORE--TRANSGENIC ANIMAL SUPPORT$117,868

P30 · FY2001 · ES

IMMUNOBIOLOGY OF AGING IN GENETICALLY ALTERED MICE$81,755

K26 · FY2001 · AG

CORE--TRANSGENIC ANIMAL SUPPORT$73,467

P30 · FY2001 · ES

DERIVATION OF BABOON EMBRYONIC STEM CELL LINES$0

P51 · FY2001 · RR

TRANSGENIC ANIMAL MODEL DEVELOPMENT--PKR PROTEIN KINASE$195,486

R24 · FY2000 · RR

CORE--TRANSGENIC ANIMAL MODEL DEVELOPMENT$193,750

P30 · FY2000 · AG

CORE--TRANSGENIC ANIMAL SUPPORT$117,868

P30 · FY2000 · ES

CORE--TRANSGENIC ANIMAL SUPPORT$117,868

P30 · FY2000 · ES

IMMUNOBIOLOGY OF AGING IN GENETICALLY ALTERED MICE$79,375

K26 · FY2000 · AG

DERIVATION OF BABOON EMBRYONIC STEM CELL LINES$74,623

P51 · FY2000 · RR